Annual ROE
-54.52%
-11.70%-27.32%
December 31, 2023
Summary
- As of February 7, 2025, DAWN annual return on equity is -54.52%, with the most recent change of -11.70% (-27.32%) on December 31, 2023.
- During the last 3 years, DAWN annual ROE has fallen by -129.25% (-172.96%).
- DAWN annual ROE is now -146.06% below its all-time high of 118.37%, reached on December 31, 2019.
Performance
DAWN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-22.40%
+27.61%+55.21%
September 30, 2024
Summary
- As of February 7, 2025, DAWN quarterly return on equity is -22.40%, with the most recent change of +27.61% (+55.21%) on September 30, 2024.
- Over the past year, DAWN quarterly ROE has increased by +29.26% (+56.64%).
- DAWN quarterly ROE is now -125.45% below its all-time high of 88.00%, reached on March 31, 2021.
Performance
DAWN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DAWN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.3% | +56.6% |
| 3 y3 years | -173.0% | +41.5% |
| 5 y5 years | -146.1% | +41.5% |
DAWN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -117.0% | at low | at high | +60.9% |
| 5 y | 5-year | -146.1% | at low | -125.5% | +78.9% |
| alltime | all time | -146.1% | at low | -125.5% | +78.9% |
Day One Biopharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -22.40%(-55.2%) |
| Jun 2024 | - | -50.01%(-12.7%) |
| Mar 2024 | - | -57.28%(+10.9%) |
| Dec 2023 | -54.52%(+27.3%) | -51.66%(+7.2%) |
| Sep 2023 | - | -48.20%(+3.1%) |
| Jun 2023 | - | -46.75%(+3.3%) |
| Mar 2023 | - | -45.26%(+7.1%) |
| Dec 2022 | -42.82% | -42.27%(+10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -38.32%(+11.7%) |
| Jun 2022 | - | -34.32%(+18.6%) |
| Mar 2022 | - | -28.94%(-15.8%) |
| Dec 2021 | -25.13%(-133.6%) | -34.39%(-49.7%) |
| Sep 2021 | - | -68.33%(-35.5%) |
| Jun 2021 | - | -105.98%(-220.4%) |
| Mar 2021 | - | 88.00%(+17.8%) |
| Dec 2020 | 74.73%(-36.9%) | 74.71% |
| Dec 2019 | 118.37% | - |
FAQ
- What is Day One Biopharmaceuticals annual return on equity?
- What is the all time high annual ROE for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual ROE year-on-year change?
- What is Day One Biopharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly ROE year-on-year change?
What is Day One Biopharmaceuticals annual return on equity?
The current annual ROE of DAWN is -54.52%
What is the all time high annual ROE for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual return on equity is 118.37%
What is Day One Biopharmaceuticals annual ROE year-on-year change?
Over the past year, DAWN annual return on equity has changed by -11.70% (-27.32%)
What is Day One Biopharmaceuticals quarterly return on equity?
The current quarterly ROE of DAWN is -22.40%
What is the all time high quarterly ROE for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly return on equity is 88.00%
What is Day One Biopharmaceuticals quarterly ROE year-on-year change?
Over the past year, DAWN quarterly return on equity has changed by +29.26% (+56.64%)